Nonaneurysmal nonperimesencephalic subarachnoid hemorrhage: is it a benign entity?

Abstract Background Although the clinical profile of patients with PMN SAH is well documented, there are scarce data available for patients with nonaneurysmal n-PMN SAH. In the present study, the clinical characteristics of patients with n-PMN SAH were analyzed and compared with those of PMN SAH and...

Full description

Saved in:
Bibliographic Details
Published inSurgical neurology Vol. 71; no. 5; pp. 566 - 571
Main Authors Gupta, Sunil K., MCh, Gupta, Rahul, MCh, Khosla, Virender K., MCh, Mohindra, Sandeep, MCh, Chhabra, Rajesh, MCh, Khandelwal, Niranjan, MD, Gupta, Vivek, MD, Mukherjee, Kanchan K., MCh, Tewari, Manoj K., MCh, Pathak, Ashish, MCh, Mathuriya, Suresh N., MCh
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.05.2009
Subjects
GOS
MCA
H&H
CTA
DSA
SAH
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background Although the clinical profile of patients with PMN SAH is well documented, there are scarce data available for patients with nonaneurysmal n-PMN SAH. In the present study, the clinical characteristics of patients with n-PMN SAH were analyzed and compared with those of PMN SAH and aneurysmal SAH. Methods Patients with spontaneous SAH, in whom the initial DSA or 3-dimensional CTA result was normal, underwent another investigation (CTA/DSA). If the results of both of these were negative, a second DSA was done after 4 to 6 weeks. Patients in whom even the second DSA failed to reveal an aneurysm or any other vascular abnormality were labeled as nonaneurysmal SAH. Within this group, 2 different types were identified: PMN SAH and n-PMN SAH. Results There were 61 patients in whom the results of the first DSA and CTA were both negative. In 2 of these patients, an aneurysm was demonstrated at a second DSA. Seven patients died before a second DSA could be done. After excluding these, there were 18 patients with PMN SAH and 34 with n-PMN SAH. There was no mortality in these patients; and at a mean follow-up of 1.8 years, all patients with PMN SAH and 94.1% of patients with n-PMN SAH had a good outcome. Associated comorbid illnesses were more frequent in patients with PMN SAH and n-PMN SAH as compared with the aneurysmal SAH patients. Conclusions Once an aneurysm is definitely excluded, patients with n-PMN SAH have a good outcome, and like PMN SAH, have a benign clinical course. However, a second DSA is mandatory to avoid missing an aneurysm or any other vascular lesion.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0090-3019
1879-3339
DOI:10.1016/j.surneu.2008.04.021